{"id":75350,"date":"2024-08-15T10:04:40","date_gmt":"2024-08-15T08:04:40","guid":{"rendered":"https:\/\/cegat.com\/?p=75350"},"modified":"2024-08-15T13:27:51","modified_gmt":"2024-08-15T11:27:51","slug":"real-world-daten-zu-personalisierter-immuntherapie-bei-glioblastom","status":"publish","type":"post","link":"https:\/\/cegat.com\/de\/real-world-daten-zu-personalisierter-immuntherapie-bei-glioblastom\/","title":{"rendered":"Real-World-Daten zu personalisierter Immuntherapie bei Glioblastom"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container has-pattern-background has-mask-background nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:0px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-text fusion-text-1\"><p style=\"text-align: justify;\">In einem jetzt ver\u00f6ffentlichten Artikel in Nature Communications werden 173 Patientinnen und Patienten mit der Diagnose Glioblastom beschrieben, die zus\u00e4tzlich zu ihrem Therapieregime auch eine vollst\u00e4ndig personalisierte Neoantigen-basierte Peptidimpfung bekommen haben. Die Daten zeigen, dass der immunbasierte personalisierte Ansatz in einem klinischen Setting machbar und vor allem gut vertr\u00e4glich ist. Die Patientinnen und Patienten, die eine Immunantwort gegen mehrere Neoantigene ausbilden, haben einen signifikanten \u00dcberlebensvorteil im Vergleich zu denjenigen, die keine Immunantworten zeigen. Die Daten sollen nun im Rahmen einer kontrollierten Zulassungsstudie \u00fcberpr\u00fcft werden. Erfreulicherweise sind viele Patientinnen und Patienten am Leben und dankbar, dass die Daten f\u00fcr die Wissenschaft zug\u00e4nglich sind. Die Hoffnung ist, dass eines Tages allen Betroffenen Zugang zu individualisierten Immuntherapien erm\u00f6glicht werden kann. Unsere Daten sind sicher ein wichtiger Schritt in diese Richtung.<\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-bottom:30px;width:100%;\"><\/div><div class=\"fusion-builder-row fusion-builder-row-inner fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"--awb-flex-grow:0;--awb-flex-grow-medium:0;--awb-flex-grow-small:0;--awb-flex-shrink:0;--awb-flex-shrink-medium:0;--awb-flex-shrink-small:0;width:104% !important;max-width:104% !important;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-0 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:50%;--awb-margin-top-large:0px;--awb-spacing-right-large:3.84%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:3.84%;--awb-width-medium:50%;--awb-order-medium:0;--awb-spacing-right-medium:3.84%;--awb-spacing-left-medium:3.84%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\" data-scroll-devices=\"small-visibility,medium-visibility,large-visibility\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div ><a class=\"fusion-button button-flat fusion-button-default-size button-custom fusion-button-default button-1 fusion-button-span-yes fusion-button-default-type\" style=\"--button_accent_color:var(--awb-color6);--button_border_color:rgba(0,0,0,0.5);--button_accent_hover_color:var(--awb-color5);--button_border_hover_color:#e1e1e1;--button_border_width-top:1px;--button_border_width-right:1px;--button_border_width-bottom:1px;--button_border_width-left:1px;--button_gradient_top_color:rgba(225,225,225,0);--button_gradient_bottom_color:rgba(225,225,225,0);--button_gradient_top_color_hover:var(--awb-color7);--button_gradient_bottom_color_hover:var(--awb-color7);\" target=\"_self\" href=\"https:\/\/cegat.com\/de\/diagnostik\/tumorerkrankungen\/\"><span class=\"fusion-button-text awb-button__text awb-button__text--default\">Erfahren Sie mehr \u00fcber unsere Tumor-Diagnostik<\/span><\/a><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-1 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:50%;--awb-margin-top-large:0px;--awb-spacing-right-large:3.84%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:3.84%;--awb-width-medium:50%;--awb-order-medium:0;--awb-spacing-right-medium:3.84%;--awb-spacing-left-medium:3.84%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div ><a class=\"fusion-button button-flat fusion-button-default-size button-custom fusion-button-default button-2 fusion-button-span-yes fusion-button-default-type\" style=\"--button_accent_color:var(--awb-color6);--button_border_color:rgba(0,0,0,0.5);--button_accent_hover_color:var(--awb-color5);--button_border_hover_color:#e1e1e1;--button_border_width-top:1px;--button_border_width-right:1px;--button_border_width-bottom:1px;--button_border_width-left:1px;--button_gradient_top_color:rgba(225,225,225,0);--button_gradient_bottom_color:rgba(225,225,225,0);--button_gradient_top_color_hover:var(--awb-color7);--button_gradient_bottom_color_hover:var(--awb-color7);\" target=\"_self\" href=\"https:\/\/cegat.com\/de\/a-real-world-observation-of-patients-with-glioblastoma-treated-with-a-personalized-peptide-vaccine\/\"><span class=\"fusion-button-text awb-button__text awb-button__text--default\">Lesen Sie die Publikation<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":25,"featured_media":54928,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[112],"tags":[],"class_list":["post-75350","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Real-World-Daten zu personalisierter Immuntherapie bei Glioblastom<\/title>\n<meta name=\"description\" content=\"173 Patientinnen und Patienten mit der Diagnose Glioblastom haben eine personalisierte Neoantigen-basierte Peptidimpfung bekommen.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cegat.com\/de\/real-world-daten-zu-personalisierter-immuntherapie-bei-glioblastom\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Real-World-Daten zu personalisierter Immuntherapie bei Glioblastom\" \/>\n<meta property=\"og:description\" content=\"173 Patientinnen und Patienten mit der Diagnose Glioblastom haben eine personalisierte Neoantigen-basierte Peptidimpfung bekommen.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cegat.com\/de\/real-world-daten-zu-personalisierter-immuntherapie-bei-glioblastom\/\" \/>\n<meta property=\"og:site_name\" content=\"CeGaT GmbH\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CeGaT.GmbH\/?locale=de_DE\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-15T08:04:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-15T11:27:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cegat.com\/wp-content\/uploads\/2022\/11\/CeGaT_KV_Neuigkeiten_Veroeffentlichungen.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1500\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"lschmidlin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/cegat.com\\\/de\\\/real-world-daten-zu-personalisierter-immuntherapie-bei-glioblastom\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cegat.com\\\/de\\\/real-world-daten-zu-personalisierter-immuntherapie-bei-glioblastom\\\/\"},\"author\":{\"name\":\"lschmidlin\",\"@id\":\"https:\\\/\\\/cegat.com\\\/de\\\/#\\\/schema\\\/person\\\/fdd58c0913e0b6435e09cffa59a6504a\"},\"headline\":\"Real-World-Daten zu personalisierter Immuntherapie bei Glioblastom\",\"datePublished\":\"2024-08-15T08:04:40+00:00\",\"dateModified\":\"2024-08-15T11:27:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/cegat.com\\\/de\\\/real-world-daten-zu-personalisierter-immuntherapie-bei-glioblastom\\\/\"},\"wordCount\":2053,\"image\":{\"@id\":\"https:\\\/\\\/cegat.com\\\/de\\\/real-world-daten-zu-personalisierter-immuntherapie-bei-glioblastom\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cegat.com\\\/wp-content\\\/uploads\\\/2022\\\/11\\\/CeGaT_KV_Neuigkeiten_Veroeffentlichungen.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cegat.com\\\/de\\\/real-world-daten-zu-personalisierter-immuntherapie-bei-glioblastom\\\/\",\"url\":\"https:\\\/\\\/cegat.com\\\/de\\\/real-world-daten-zu-personalisierter-immuntherapie-bei-glioblastom\\\/\",\"name\":\"Real-World-Daten zu personalisierter Immuntherapie bei Glioblastom\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cegat.com\\\/de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/cegat.com\\\/de\\\/real-world-daten-zu-personalisierter-immuntherapie-bei-glioblastom\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/cegat.com\\\/de\\\/real-world-daten-zu-personalisierter-immuntherapie-bei-glioblastom\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cegat.com\\\/wp-content\\\/uploads\\\/2022\\\/11\\\/CeGaT_KV_Neuigkeiten_Veroeffentlichungen.jpg\",\"datePublished\":\"2024-08-15T08:04:40+00:00\",\"dateModified\":\"2024-08-15T11:27:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/cegat.com\\\/de\\\/#\\\/schema\\\/person\\\/fdd58c0913e0b6435e09cffa59a6504a\"},\"description\":\"173 Patientinnen und Patienten mit der Diagnose Glioblastom haben eine personalisierte Neoantigen-basierte Peptidimpfung bekommen.\",\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cegat.com\\\/de\\\/real-world-daten-zu-personalisierter-immuntherapie-bei-glioblastom\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/cegat.com\\\/de\\\/real-world-daten-zu-personalisierter-immuntherapie-bei-glioblastom\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cegat.com\\\/wp-content\\\/uploads\\\/2022\\\/11\\\/CeGaT_KV_Neuigkeiten_Veroeffentlichungen.jpg\",\"contentUrl\":\"https:\\\/\\\/cegat.com\\\/wp-content\\\/uploads\\\/2022\\\/11\\\/CeGaT_KV_Neuigkeiten_Veroeffentlichungen.jpg\",\"width\":1500,\"height\":800,\"caption\":\"Keyvisual zu Neuigkeiten und Ver\u00f6ffentlichungen\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cegat.com\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/cegat.com\\\/de\\\/\",\"name\":\"CeGaT GmbH\",\"description\":\"Genetic Insights You Can Trust\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cegat.com\\\/de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/cegat.com\\\/de\\\/#\\\/schema\\\/person\\\/fdd58c0913e0b6435e09cffa59a6504a\",\"name\":\"lschmidlin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Real-World-Daten zu personalisierter Immuntherapie bei Glioblastom","description":"173 Patientinnen und Patienten mit der Diagnose Glioblastom haben eine personalisierte Neoantigen-basierte Peptidimpfung bekommen.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cegat.com\/de\/real-world-daten-zu-personalisierter-immuntherapie-bei-glioblastom\/","og_locale":"de_DE","og_type":"article","og_title":"Real-World-Daten zu personalisierter Immuntherapie bei Glioblastom","og_description":"173 Patientinnen und Patienten mit der Diagnose Glioblastom haben eine personalisierte Neoantigen-basierte Peptidimpfung bekommen.","og_url":"https:\/\/cegat.com\/de\/real-world-daten-zu-personalisierter-immuntherapie-bei-glioblastom\/","og_site_name":"CeGaT GmbH","article_publisher":"https:\/\/www.facebook.com\/CeGaT.GmbH\/?locale=de_DE","article_published_time":"2024-08-15T08:04:40+00:00","article_modified_time":"2024-08-15T11:27:51+00:00","og_image":[{"width":1500,"height":800,"url":"https:\/\/cegat.com\/wp-content\/uploads\/2022\/11\/CeGaT_KV_Neuigkeiten_Veroeffentlichungen.jpg","type":"image\/jpeg"}],"author":"lschmidlin","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cegat.com\/de\/real-world-daten-zu-personalisierter-immuntherapie-bei-glioblastom\/#article","isPartOf":{"@id":"https:\/\/cegat.com\/de\/real-world-daten-zu-personalisierter-immuntherapie-bei-glioblastom\/"},"author":{"name":"lschmidlin","@id":"https:\/\/cegat.com\/de\/#\/schema\/person\/fdd58c0913e0b6435e09cffa59a6504a"},"headline":"Real-World-Daten zu personalisierter Immuntherapie bei Glioblastom","datePublished":"2024-08-15T08:04:40+00:00","dateModified":"2024-08-15T11:27:51+00:00","mainEntityOfPage":{"@id":"https:\/\/cegat.com\/de\/real-world-daten-zu-personalisierter-immuntherapie-bei-glioblastom\/"},"wordCount":2053,"image":{"@id":"https:\/\/cegat.com\/de\/real-world-daten-zu-personalisierter-immuntherapie-bei-glioblastom\/#primaryimage"},"thumbnailUrl":"https:\/\/cegat.com\/wp-content\/uploads\/2022\/11\/CeGaT_KV_Neuigkeiten_Veroeffentlichungen.jpg","articleSection":["News"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/cegat.com\/de\/real-world-daten-zu-personalisierter-immuntherapie-bei-glioblastom\/","url":"https:\/\/cegat.com\/de\/real-world-daten-zu-personalisierter-immuntherapie-bei-glioblastom\/","name":"Real-World-Daten zu personalisierter Immuntherapie bei Glioblastom","isPartOf":{"@id":"https:\/\/cegat.com\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cegat.com\/de\/real-world-daten-zu-personalisierter-immuntherapie-bei-glioblastom\/#primaryimage"},"image":{"@id":"https:\/\/cegat.com\/de\/real-world-daten-zu-personalisierter-immuntherapie-bei-glioblastom\/#primaryimage"},"thumbnailUrl":"https:\/\/cegat.com\/wp-content\/uploads\/2022\/11\/CeGaT_KV_Neuigkeiten_Veroeffentlichungen.jpg","datePublished":"2024-08-15T08:04:40+00:00","dateModified":"2024-08-15T11:27:51+00:00","author":{"@id":"https:\/\/cegat.com\/de\/#\/schema\/person\/fdd58c0913e0b6435e09cffa59a6504a"},"description":"173 Patientinnen und Patienten mit der Diagnose Glioblastom haben eine personalisierte Neoantigen-basierte Peptidimpfung bekommen.","inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cegat.com\/de\/real-world-daten-zu-personalisierter-immuntherapie-bei-glioblastom\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/cegat.com\/de\/real-world-daten-zu-personalisierter-immuntherapie-bei-glioblastom\/#primaryimage","url":"https:\/\/cegat.com\/wp-content\/uploads\/2022\/11\/CeGaT_KV_Neuigkeiten_Veroeffentlichungen.jpg","contentUrl":"https:\/\/cegat.com\/wp-content\/uploads\/2022\/11\/CeGaT_KV_Neuigkeiten_Veroeffentlichungen.jpg","width":1500,"height":800,"caption":"Keyvisual zu Neuigkeiten und Ver\u00f6ffentlichungen"},{"@type":"WebSite","@id":"https:\/\/cegat.com\/de\/#website","url":"https:\/\/cegat.com\/de\/","name":"CeGaT GmbH","description":"Genetic Insights You Can Trust","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cegat.com\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/cegat.com\/de\/#\/schema\/person\/fdd58c0913e0b6435e09cffa59a6504a","name":"lschmidlin"}]}},"_links":{"self":[{"href":"https:\/\/cegat.com\/de\/wp-json\/wp\/v2\/posts\/75350","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cegat.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cegat.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cegat.com\/de\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/cegat.com\/de\/wp-json\/wp\/v2\/comments?post=75350"}],"version-history":[{"count":0,"href":"https:\/\/cegat.com\/de\/wp-json\/wp\/v2\/posts\/75350\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cegat.com\/de\/wp-json\/wp\/v2\/media\/54928"}],"wp:attachment":[{"href":"https:\/\/cegat.com\/de\/wp-json\/wp\/v2\/media?parent=75350"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cegat.com\/de\/wp-json\/wp\/v2\/categories?post=75350"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cegat.com\/de\/wp-json\/wp\/v2\/tags?post=75350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}